| Cobimetinib | hsa00230 | Purine metabolism | 3.35E-02 | 2 | Q7LG56, P51828 | RRM2B, ADCY7 | More | |
| Cobimetinib | hsa00330 | Arginine and proline metabolism | 2.73E-02 | 1 | P17707 | AMD1 | More | |
| Cobimetinib | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.11E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | |
| Cobimetinib | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 8.72E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | |
| Cobimetinib | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.46E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | |
| Cobimetinib | hsa04114 | Oocyte meiosis | 2.05E-02 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | |
| Cobimetinib | hsa04370 | VEGF signaling pathway | 1.29E-02 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | |
| Cobimetinib | hsa04727 | GABAergic synapse | 4.60E-02 | 2 | P51828, P46459 | ADCY7, NSF | More | |
| Cobimetinib | hsa04912 | GnRH signaling pathway | 3.96E-02 | 2 | P51828, P45985 | ADCY7, MAP2K4 | More | |
| Cobimetinib | hsa04914 | Progesterone-mediated oocyte maturation | 2.66E-02 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | |
| Cobimetinib | hsa04935 | Growth hormone synthesis, secretion and action | 4.60E-02 | 2 | P51828, P45985 | ADCY7, MAP2K4 | More | |
